InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the full record of transactions filed by Qiming U.S. Healthcare Fund II, L.P.. Director active across 3 companies, notably Elevation Oncology, Inc.. In total, 3 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €3.7m. Activity tracked since 29 June 2021. The latest transaction was filed on 27 January 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Qiming U.S. Healthcare Fund II, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
2,666,666 shares@ US$1.50100.0% of flowVoting Common StockSEC:0001209191-23-024058:0
Canonical exit: 27 Apr 2023 (T+90)
3,310,228 shares0Common StockSEC:0000899243-21-031149:0
1,656,577 shares0Common StockSEC:0001209191-21-044606:0
3 of 3 declarations
About Qiming U.S. Healthcare Fund II, L.P.
Qiming U.S. Healthcare Fund II, L.P. is a declarant linked to Icosavax, Inc., Elevation Oncology, Inc. and Jasper Therapeutics, Inc. The record shows 5 filings in total, and, across the sampled recent filings, purchases of EUR 3671599, with no sales, between 2021-07-01 and 2023-04-11.
